Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Martin Marietta Materials is a leading American supplier of aggregates and heavy building materials, primarily serving the construction industry. The company's core product portfolio includes crushed stone, sand, gravel, cement, and ready-mixed concrete used in infrastructure and commercial projects. Beyond construction, the company operates a Magnesia Specialties division that produces high-purity magnesium oxide and magnesium hydroxide. These chemical products serve diverse sectors, including environmental, industrial, and pharmaceutical markets. In the healthcare space, their magnesium derivatives are utilized as active ingredients in antacids and laxatives, as well as in nutritional supplements. Headquartered in Raleigh, North Carolina, Martin Marietta is a member of the S&P 500 Index and operates across the United States, Canada, and the Bahamas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Martin Marietta Materials.